The effects of histamine and prostaglandin D2 on rat mast-cell cyclic AMP and mediator release

Insights

Histamine can transiently increase cyclic AMP in rat peritoneal mast cells (RPMCs) and suppress serotonin release, but only at very high concentrations and when phosphodiesterase is inhibited. This histamine action is unlikely to have physiological significance.

Area of Science:

  • Immunology
  • Pharmacology

Background:

  • Histamine's role in mast cell secretion is debated.
  • Investigating histamine's effect on rat peritoneal mast cells (RPMCs) is crucial for understanding immune responses.

Purpose of the Study:

  • To examine histamine's influence on RPMC cyclic AMP levels and serotonin release.
  • To determine the specific histamine receptor subtype involved in modulating mast cell secretion.

Main Methods:

  • Assessed effects of histamine and prostaglandin D2 (PGD2) on cyclic AMP and 3H-serotonin (5-HT) release from RPMCs.
  • Utilized aminophylline to inhibit phosphodiesterase activity.
  • Tested specific H-1 and H-2 receptor agonists and antagonists.

Main Results:

  • PGD2 increased cyclic AMP and inhibited 5-HT release (with aminophylline).
  • Histamine (up to 1000 microM) was ineffective without aminophylline.
  • High histamine concentrations (1000 microM) with aminophylline transiently increased cyclic AMP and suppressed 5-HT release.
  • H-1 receptor agonists mimicked histamine's suppressive effect, while H-2 modulators had no influence.

Conclusions:

  • Histamine can modulate RPMC secretion under conditions of impaired phosphodiesterase activity.
  • The observed effect requires extremely high histamine concentrations.
  • This histamine action is unlikely to be physiologically significant.

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Adrenergic Receptors: β Subtype01:26

Adrenergic Receptors: β Subtype

β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Acute Inflammation III: Local and Systemic Effects01:25

Acute Inflammation III: Local and Systemic Effects

Acute inflammation produces a coordinated set of local and systemic changes that limit injury, eliminate pathogens, and initiate repair. These responses arise within minutes of infection, trauma, or chemical insult and are driven by vascular alterations and leukocyte-derived mediators. When the stimulus resolves, the reaction typically abates within days.Local EffectsAt the site of injury, arteriolar vasodilation increases blood flow, resulting in redness and warmth. Simultaneously, increased...